...
首页> 外文期刊>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience >Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.
【24h】

Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.

机译:腺苷A2A受体拮抗剂可缓解多巴胺D2受体缺陷型小鼠的运动障碍。

获取原文
获取原文并翻译 | 示例

摘要

In Parkinson's disease a degeneration of dopaminergic neurons of the nigrostriatal pathway is observed. Loss of dopaminergic regulation of striatal neuron activity results in altered motor functions. Adenosine A2A (A2AR) and dopamine D2 (D2R) receptors are colocalized in striatal medium spiny neurons. It has been proposed that adenosine binding to A2AR lowers the affinity of dopamine for D2R, thus modulating the function of this receptor. Absence of D2R in knockout mice (D2R-/-) results in impaired locomotion and coordinated movements. This indicates that absence of dopamine in Parkinson's disease might principally affect D2R-mediated effects with regard to locomotor functions. A2AR-selective antagonists have been demonstrated to have anti- parkinsonian activities in various models of Parkinson's disease in rodents and nonhuman primates. In this article, D2R-/- mice were used to explore the possibility that an A2AR antagonist might reestablish their motor impairment. Interestingly, blockade of A2AR rescues the behavioral parameters altered in D2R-/- mice. In addition, the level of expression of enkephalin and substance P, which were altered in D2R-/-, were also reestablished to normal levels after A2AR antagonist treatment. These results show that A2AR and D2R have antagonistic and independent activities in controlling neuronal and motor functions in the basal ganglia. They also provide evidence that selective A2AR antagonists can exhibit their anti-parkinsonian activities through a nondopaminergic mechanism.
机译:在帕金森氏病中,观察到黑质纹状体途径的多巴胺能神经元变性。纹状体神经元活性的多巴胺能调节丧失导致运动功能改变。腺苷A2A(A2AR)和多巴胺D2(D2R)受体共定位于纹状体中棘神经元中。已经提出,腺苷与A2AR的结合降低了多巴胺对D2R的亲和力,从而调节了该受体的功能。基因敲除小鼠(D2R-/-)缺乏D2R会导致运动能力和协调性运动受损。这表明在帕金森氏病中缺乏多巴胺可能主要影响D2R介导的运动功能影响。在啮齿动物和非人类灵长类动物的各种帕金森氏病模型中,A2AR选择性拮抗剂已被证明具有抗帕金森氏症的活性。在本文中,D2R-/-小鼠用于探讨A2AR拮抗剂可能会重建其运动障碍的可能性。有趣的是,阻断A2AR可以挽救D2R-/-小鼠中行为参数的改变。另外,在A2AR拮抗剂治疗后,在D2R-/-中改变的脑啡肽和P物质的表达水平也恢复到正常水平。这些结果表明,A2AR和D2R在控制基底神经节的神经元和运动功能方面具有拮抗和独立的活性。他们还提供了证据,表明选择性的A2AR拮抗剂可以通过非多巴胺能机制发挥抗帕金森病的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号